11/14/2022Snapshot of BMI System Financial Performance in 3Qs/2022

11/14/2022Fire Sale! China's "Warren Buffett" Races To Sell Assets (Forbes)

11/14/2022Fundraising Continued to Drop in October, No Drugmaker Raised More Tha...

11/11/2022AstraZeneca Launches First Alexion Rare Disease Therapy for Patients i...

11/11/2022NMPA Solicits Comments on the Special Rules for TCM Registration

11/11/2022Harbour BioMed Enters into a License and Collaboration Agreement with ...

11/11/2022Review of A Share-listed Chinese MedPharm Cos in Q3/2022

11/11/2022PwC: Review of China's Pharmaceutical & Life Sciences M&A Deals in 202...

11/10/2022AstraZeneca Reports Strong Quarterly Results with China Growth Despite...

11/10/2022China's Biopharma Industry: Market Prospects, Investment Paths (China ...

11/10/2022Under Geopolitics and Market Rout, Chinese Biotechs Center on Data Qua...

11/9/2022China Issues the 14th Five-Year Plan for Universal Health Informatizat...

11/6/2022Germany Pharma CEOs Visit China with German Chancellor Scholz

11/4/2022NMPA Announces Package Insert Revision of Methotrexate Oral Formulatio...

11/4/2022Recent Executive Moves

11/4/2022China Clarifies Regulations for Online Prescription Drug Sales, But Th...

11/3/2022NMPA Releases the Draft List of Drugs Prohibited for Online Sales for ...

11/1/2022TPG Capital Asia Acquires Majority Stake in iNova Pharmaceuticals

11/1/2022Pharmaniaga Partners JD.com to Enter China Healthcare Market

11/1/2022China Bars Celebrities from Endorsing Products to Boost 'Traditional V...

10/31/2022Big Pharma Dominated the Deals Space in September (PharmaDJ)

10/31/2022Financial-related Company News Digest (October 2022)

10/31/2022Novartis Abandons US PD-1 Submission Plan for Tislelizumab

10/28/2022Recent Executive Moves

10/27/2022NMPA Announces Package Insert Revision of Domperidone Formulations

10/27/2022Semiconductor Export Curbs Hitting China To Be Followed By Biotech and...

10/26/2022WuXi Bio Launches 48,000L Commercial Drug Substance Manufacturing Faci...

10/25/2022Crisis or Opportunity? Biotech Companies Are at A Crossroads in The St...

10/24/2022NASDAQ-listed BIMI Disposes Acquired Chinese Pharma Distributor

10/21/2022Recent Executive Moves

Page:63/361 Total number of articles:10826: [First][<<] [61] [62] [63] [64] [65] [>>] [End]